Abstract:Heterogeneity is ubiquitous in stem cells (SC), cancer cells (CS), and cancer SC (CSC). This heterogeneity manifests in the form of diverse sub-populations of SC, CS, and CSC with self-renewal and unique regeneration capacity. Moreover, the progeny of CSC possess multiple plasticity and cancerous characteristics. Many studies have demonstrated that cancer heterogeneity is among the greatest obstacles to successful anti-cancer therapy. This leads to incomplete therapy and transitory efficacy. Furthermore, numerous micro-metastases lead to the spread of tumor cells widely across the body; this is the beginning of metastasis. Epigenetic processes (DNA methylation and histone remodification) represent sources of heterogeneity. In this study, we develop a mathematical model to quantify the heterogeneity of SC, CS, and CSC, taking into consideration both genetic and epigenetic effects. We reveal the roles and physical mechanisms of heterogeneity in SC, CSC, and cancer cells. Under the adiabatic regime (relatively fast regulatory binding and effective coupling among genes), seven native states (SC, CSC, cancer, premalignant, normal, lesion, and hyperplasia) emerge. Under the non-adiabatic regime (relatively slow regulatory binding and effective weak coupling among genes), SC, CS, CSC, and differentiated states emerge and become diffusive, partially explaining the origin of heterogeneity. In other words, slow regulatory binding that mimics epigenetic effects can give rise to heterogeneity. Moreover, we calculated the entropy production rate and Fano factor, which can be used to quantify the thermodynamic cost and the degrees of the variations or the fluctuations as the parameter ω (representing the speed of regulatory binding/unbinding relative to the synthesis/degradation) changes. Elucidating the origins of heterogeneity and the dynamical relationships between intra-tumoral cells has a clear clinical significance and will improve the understanding of the cellular basis of treatment response, therapeutic resistance, and cancer metastasis.

Systems Heterogeneity: an Integrative Way to Understand Cancer Heterogeneity.

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

A physical mechanism of heterogeneity in stem cell, cancer and cancer stem cell

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Epigenetic Heterogeneity in Cancer

A Physical Mechanism of Heterogeneity and Micro-Metastasis in Stem Cells, Cancer Cells, and Cancer Stem Cells

Progress in the Clinical Detection of Heterogeneity in Breast Cancer.

Heterogeneity of the tumor immune microenvironment and its clinical relevance

Heterogeneity Between Primary Colon Carcinoma and Paired Lymphatic and Hepatic Metastases.

The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness

Cellular Heterogeneity and Molecular Evolution in Cancer

Tumor Heterogeneity: The Challenge of Precision Medicine

Heterogeneity Analysis Via Integrating Multi-Sources High-Dimensional Data with Applications to Cancer Studies

Clinical management of breast cancer heterogeneity

Tumor Heterogeneity Ubiquitous and Underestimated

Investigating intratumour heterogeneity by single-cell sequencing.

Molecular heterogeneity in breast cancer: State of the science and implications for patient care

Correction: Breast Cancer Heterogeneity and Its Implication in Personalized Precision Therapy

Using Single‐cell Multiple Omics Approaches to Resolve Tumor Heterogeneity

Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity